Lack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP).-Reference-Cited by-同舟云学术

Lack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP).

Published:1989-02 Issue:2 Volume:27 Page:257-261
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Barnett JA,Brenner DE,Creaven PJ,Lalka D.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1989.tb05358.x/fullpdf

Reference21 articles.

1. Phase I clinical trial of recombinant human tumor necrosis factor.;Creaven;Cancer Chemother. Pharmac.,1987

2. Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro.;Darlington;J. cell Biol.,1986

3. Influence of enhanced alpha-1-acid glycoprotein concentration on protein binding, pharmacokinetics and antiarrhythmic effect of lidocaine in the dog.;Rick;J. Pharmac. exp. Ther.,1987

4. Current concepts: Lymphokines.;Dinarello;New Engl. J. Med.,1987

5. Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography.;Drayer;J. lab. clin. Med.,1977

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluorescent probing of the ligand-binding ability of blood plasma in the acute-phase response;Clinical and Experimental Medicine;2002-11

2. Pharmacokinetics of Quinine, Chloroquine and Amodiaquine;Clinical Pharmacokinetics;1996-04

3. Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria.;British Journal of Clinical Pharmacology;1991-09